uridine has been researched along with Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JL; Disney, MD; Fountain, MA; VanEtten, DM; Yildirim, I | 1 |
| Garcia, RA; Hu, Z; Li, D; Liu, LS; Saydoff, JA; von Borstel, RW | 1 |
| Beal, MF; Brenneman, D; Browne, SE; Burr, H; Cardin, S; Garcia, RA; Gonzalez, A; Gregorio, J; Hu, Z; Liu, L; Saydoff, JA; Sheng, J; von Borstel, RW | 1 |
3 other study(ies) available for uridine and Huntington Disease
| Article | Year |
|---|---|
Structure and Dynamics of RNA Repeat Expansions That Cause Huntington's Disease and Myotonic Dystrophy Type 1.
Topics: 3' Untranslated Regions; Base Pairing; Energy Transfer; Exons; Humans; Huntingtin Protein; Huntington Disease; Hydrogen Bonding; Models, Molecular; Molecular Dynamics Simulation; Mutation; Myotonic Dystrophy; Myotonin-Protein Kinase; Nuclear Magnetic Resonance, Biomolecular; Nucleic Acid Conformation; Nucleotide Motifs; RNA Folding; RNA, Messenger; Trinucleotide Repeat Expansion; Uridine | 2017 |
Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.
Topics: Acetates; Administration, Oral; Animals; Huntington Disease; Male; Mice; Mitochondria; Motor Activity; Nerve Degeneration; Nitro Compounds; Prodrugs; Propionates; Uridine; Weight Loss | 2003 |
Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease.
Topics: Acetates; Administration, Oral; Analysis of Variance; Animals; Cerebral Cortex; Disease Models, Animal; Female; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; Motor Activity; Neostriatum; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Prodrugs; Rotarod Performance Test; Uridine | 2006 |